Hepatitis C Elimination in the Netherlands
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
EPIC-P Intervention
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
The RESPOND Outcomes Study
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
- Status
- COMPLETED
- Phase
- PHASE2
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
- Status
- COMPLETED
- Phase
- PHASE2
Eliminate Hepatitis C/EC Partnership Evaluation Protocol
- Status
- UNKNOWN
- Phase
- NA
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC
- Status
- TERMINATED
- Phase
- PHASE2
Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
- Status
- COMPLETED
- Phase
- N/A
Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE
- Status
- COMPLETED
- Phase
- PHASE4